Dallah Healthcare CoSAU:4004 92 Operating Margin % is 10.83% as of Mar. 2026, which is 36% below its 10-year median of 16.96. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼204.73 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 77.4% on this metric.
Dallah Healthcare Co operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Dallah Healthcare Co's Operating Margin % or its related term are showing as below:
SAU:4004'
s Operating Margin % Range Over the Past 10 Years
Min: 10.89 Med: 16.96 Max: 25.42
Current: 12.86
SAU:4004's Operating Margin % is ranked better than 77.4% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs SAU:4004: 12.86
Dallah Healthcare Co's 5-Year Average Operating Margin % Growth Rate was 5.90% per year.
Dallah Healthcare Co (SAU:4004) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Dallah Healthcare Co Operating Margin % Related Terms
Dallah Healthcare Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Operating Margin % falls into.
Dallah Healthcare Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Dallah Healthcare Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Operating Margin % of 10.83% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Dallah Healthcare Co and its competitors. This is 36% below median its historical median of 16.96. Over the past decade, Dallah Healthcare Co's Operating Margin % has ranged from 10.89 to 25.42. According to the industry distribution chart, Dallah Healthcare Co ranks #151 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 22.6%.
Is Dallah Healthcare Co's Operating Margin % too high?
Dallah Healthcare Co's current Operating Margin % of 10.83% is 36% below median its 10-year median of 16.96. Over the past 10 years, this metric has ranged from a low of 10.89 to a high of 25.42. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Dallah Healthcare Co's value of 10.83% is 123.5% above this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #151 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #151 out of 668 companies for Operating Margin %. This places Dallah Healthcare Co in the top 23% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.85. Dallah Healthcare Co's value of 10.83% is 123.5% above this benchmark. Historically, Dallah Healthcare Co's own Operating Margin % has ranged from 10.89 to 25.42 over the past decade. While the company's 10-year median is 16.96 vs. the industry median of 4.85, Dallah Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current Operating Margin % of 10.83% is 123.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current Operating Margin % is 10.83%, which is 36% below median its own 10-year median of 16.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼204.73, compared to a current price of ﷼112.00 — trading 45.3% below its estimated fair value. The current Operating Margin % is 10.83%, which is 36% below median its 10-year median of 16.96 and 123.5% above the Healthcare Providers & Services industry median of 4.85. Dallah Healthcare Co's overall GF Score™ is 92/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Operating Margin % is 10.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼112.00 is trading 45.3% below its estimated GF Value™ of ﷼204.73.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
Operating Margin %: 10.83% (36% below median its 10-year median of 16.96)
GF Value™: ﷼204.73 vs. price of ﷼112.00 (45.3% below fair value)
Industry Position: 123.5% above the Healthcare Providers & Services median (#151 of 668)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score
Get the complete analysis for SAU:4004
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
